Everolimus as First-Line Therapy in Treating Patients With Prostate Cancer

NCT00976755 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
37
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Swiss Cancer Institute